Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,412 | -25,828 | -17,609 | -8,099 | -43,883 |
| Depreciation Amortization | 8,680 | 5,045 | 3,410 | 1,627 | 3,278 |
| Income taxes - deferred | -7,376 | -5,175 | -2,862 | -1,349 | -3,281 |
| Accounts receivable | -63 | -20 | -170 | 178 | 379 |
| Other Working Capital | -827 | -1,949 | -2,795 | -1,717 | 2,731 |
| Other Operating Activity | -2,856 | -1,817 | -1,109 | -997 | 11,267 |
| Operating Cash Flow | $-38,854 | $-29,744 | $-21,135 | $-10,357 | $-29,509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -693 | -493 | -401 | -228 | -2,246 |
| Other Investing Activity | -315 | -306 | -306 | -300 | -1,419 |
| Investing Cash Flow | $-1,008 | $-799 | $-707 | $-528 | $-3,665 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 471 | 467 | 0 | N/A | N/A |
| Debt Repayment | -26 | -13 | 0 | 0 | N/A |
| Common Stock Issued | 60,001 | 28,994 | 28,994 | 8,841 | 35,082 |
| Other Financing Activity | 3,177 | 3,202 | 3,198 | 3,288 | -818 |
| Financing Cash Flow | $63,623 | $32,650 | $32,192 | $12,129 | $34,264 |
| Exchange Rate Effect | 230 | -186 | -123 | -101 | 56 |
| Beginning Cash Position | 5,496 | 5,495 | 5,495 | 5,496 | 4,350 |
| End Cash Position | 29,487 | 7,416 | 15,722 | 6,638 | 5,496 |
| Net Cash Flow | $23,991 | $1,921 | $10,227 | $1,142 | $1,146 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,854 | -29,744 | -21,135 | -10,357 | -29,509 |
| Capital Expenditure | -702 | -497 | -405 | -232 | -2,277 |
| Free Cash Flow | -39,556 | -30,241 | -21,540 | -10,589 | -31,786 |